Beyond the 2020 guidelines on atrial fibrillation of the European society of cardiology

The Tasmanian Atrial Fibrillation Study (TAFS): Differences in Stroke Prevention According to Sex

(2020) Sophie M. Pilcher et al.   ANNALS OF PHARMACOTHERAPY

One-year clinical events and management of patients with atrial fibrillation hospitalized in cardiology centers: Data from the BLITZ-AF study

(2020) Roberto Cemin et al.   European Journal of Internal Medicine

Antithrombotic treatment in patients with atrial fibrillation undergoing coronary angioplasty: rational convincement and supporting evidence

(2020) Elisabetta Ricottini et al.   European Journal of Internal Medicine

Race/Ethnicity and Sex-Related Differences in Direct Oral Anticoagulant Initiation in Newly Diagnosed Atrial Fibrillation: A Retrospective Study of Medicare Data

(2020) Utibe R. Essien et al.   JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION

Lower versus Standard INR Targets in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

(2020) Arjun K. Pandey et al.   THROMBOSIS AND HAEMOSTASIS

Regular Bleeding Risk Assessment Associated with Reduction in Bleeding Outcomes: The mAFA-II Randomized Trial

(2020) Yutao Guo et al.   AMERICAN JOURNAL OF MEDICINE

From meta-analysis to the individual patient with atrial fibrillation and coronary artery disease: the complexity of antithrombotic treatment in real-world clinical practice and the need for a tailored approach

(2020) Giuseppe Boriani et al.   European Journal of Internal Medicine

Influence of BMI and geographical region on prescription of oral anticoagulants in newly diagnosed atrial fibrillation: The GLORIA-AF Registry Program

(2020) Giuseppe Boriani et al.   European Journal of Internal Medicine

Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation

(2020) Yutao Guo et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Female Sex as a Risk Modifier for Stroke Risk in Atrial Fibrillation: Using CHA2DS2-VASc versus CHA2DS2-VA for Stroke Risk Stratification in Atrial Fibrillation: A Note of Caution

(2020) Peter Brønnum Nielsen et al.   THROMBOSIS AND HAEMOSTASIS

Comprehensive Management With the ABC (Atrial Fibrillation Better Care) Pathway in Clinically Complex Patients With Atrial Fibrillation: A Post Hoc Ancillary Analysis From the AFFIRM Trial

(2020) Marco Proietti et al.   Journal of the American Heart Association

Compliance of Atrial Fibrillation Treatment with the Atrial Fibrillation Better Care (ABC) Pathway Improves the Clinical Outcomes in the Middle East Population: A Report from the Gulf Survey of Atrial Fibrillation Events (SAFE) Registry

(2020) Jakub Gumprecht et al.   Journal of Clinical Medicine

The Euro Heart Survey and EURObservational Research Programme (EORP) in atrial fibrillation registries: contribution to epidemiology, clinical management and therapy of atrial fibrillation patients over the last 20 years

(2020) Marco Vitolo et al.   Internal and Emergency Medicine

Predicting Adverse Events beyond Stroke and Bleeding with the ABC-Stroke and ABC-Bleeding Scores in Patients with Atrial Fibrillation: The Murcia AF Project

(2020) Anny Camelo-Castillo et al.   THROMBOSIS AND HAEMOSTASIS

Mobile health applications for managing atrial fibrillation for healthcare professionals and patients: a systematic review

(2020) Deirdre A Lane et al.   EUROPACE

Consumer-led screening for atrial fibrillation using consumer-facing wearables, devices and apps: A survey of health care professionals by AF-SCREEN international collaboration

(2020) Giuseppe Boriani et al.   European Journal of Internal Medicine

Direct oral anticoagulants vs non-vitamin K antagonist in atrial fibrillation: A prospective, propensity score adjusted cohort study

(2019) Marco Marietta et al.   European Journal of Internal Medicine

Incident Co-Morbidities in Patients with Atrial Fibrillation Initially with a CHA2DS2-VASc Score of 0 (Males) or 1 (Females): Implications for Reassessment of Stroke Risk in Initially ‘Low-Risk’ Patients

(2019) Tze-Fan Chao et al.   THROMBOSIS AND HAEMOSTASIS

Changes in Oral Anticoagulation Therapy over One Year in 51,000 Atrial Fibrillation Patients at Risk for Stroke: A Practice-Derived Study

(2019) Stefan Hohnloser et al.   THROMBOSIS AND HAEMOSTASIS

Non-Vitamin K Oral Anticoagulants in Comparison to Phenprocoumon in Geriatric and Non-Geriatric Patients with Non-Valvular Atrial Fibrillation

(2019) Christopher Hohmann et al.   THROMBOSIS AND HAEMOSTASIS

Levels of Evidence Supporting American College of Cardiology/American Heart Association and European Society of Cardiology Guidelines, 2008-2018

(2019) Alexander C. Fanaroff et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry

(2019) Giuseppe Boriani et al.   EUROPACE

The impact of GDF-15, a biomarker for metformin, on the risk of coronary artery disease, breast and colorectal cancer, and type 2 diabetes and metabolic traits: a Mendelian randomisation study

(2019) Shiu Lun Au Yeung et al.   DIABETOLOGIA

Screening for atrial fibrillation: Need for an integrated, structured approach

(2019) Giuseppe Boriani et al.   European Journal of Internal Medicine

Refining Stroke and Bleeding Prediction in Atrial Fibrillation by Adding Consecutive Biomarkers to Clinical Risk Scores

(2019) José Miguel Rivera-Caravaca et al.   STROKE

Improved Population-Based Clinical Outcomes of Patients with Atrial Fibrillation by Compliance with the Simple ABC (Atrial Fibrillation Better Care) Pathway for Integrated Care Management: A Nationwide Cohort Study

(2019) Minjae Yoon et al.   THROMBOSIS AND HAEMOSTASIS

Usefulness of Red Cells Distribution Width to Predict Worse Outcomes in Patients With Atrial Fibrillation

(2019) Vincenzo Livio Malavasi et al.   AMERICAN JOURNAL OF CARDIOLOGY

The Use of Biomarkers in Clinical Management Guidelines: A Critical Appraisal

(2019) María Asunción Esteve-Pastor et al.   THROMBOSIS AND HAEMOSTASIS

Fifty years of research on antithrombotic therapy: Achievements and disappointments

(2019) Jack Hirsh et al.   European Journal of Internal Medicine

Managing atrial fibrillation: the need for an individualized approach even in the emergency department

(2019) Giuseppe Boriani et al.   Internal and Emergency Medicine

The HAS-BLED, ATRIA, and ORBIT Bleeding Scores in Atrial Fibrillation Patients Using Non-Vitamin K Antagonist Oral Anticoagulants

(2018) Gregory Y.H. Lip et al.   AMERICAN JOURNAL OF MEDICINE

Comparing Bleeding Risk Assessment Focused on Modifiable Risk Factors Only Versus Validated Bleeding Risk Scores in Atrial Fibrillation

(2018) Yutao Guo et al.   AMERICAN JOURNAL OF MEDICINE

Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation

(2018) Peter Brønnum Nielsen et al.   CIRCULATION

Major knowledge gaps and system barriers to guideline implementation among European physicians treating patients with atrial fibrillation: a European Society of Cardiology international educational needs assessment

(2018) Hein Heidbuchel et al.   EUROPACE

Major bleeding and intracranial hemorrhage risk prediction in patients with atrial fibrillation: Attention to modifiable bleeding risk factors or use of a bleeding risk stratification score? A nationwide cohort study

(2018) Tze-Fan Chao et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation

(2018) Tze-Fan Chao et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effectiveness and Safety of Non–Vitamin K Oral Anticoagulants in Comparison to Phenprocoumon: Data from 61,000 Patients with Atrial Fibrillation

(2018) Edin Basic et al.   THROMBOSIS AND HAEMOSTASIS

Incident Risk Factors and Major Bleeding in Patients with Atrial Fibrillation Treated with Oral Anticoagulants: A Comparison of Baseline, Follow-up and Delta HAS-BLED Scores with an Approach Focused on Modifiable Bleeding Risk Factors

(2018) Tze-Fan Chao et al.   THROMBOSIS AND HAEMOSTASIS

Is There a Preferred Stroke Prevention Strategy for Diabetic Patients with Non-Valvular Atrial Fibrillation? Comparing Warfarin, Dabigatran and Rivaroxaban

(2018) Chih-Cheng Hsu et al.   THROMBOSIS AND HAEMOSTASIS

Dynamic Changes of CHA2DS2-VASc Score and the Risk of Ischaemic Stroke in Asian Patients with Atrial Fibrillation: A Nationwide Cohort Study

(2018) Minjae Yoon et al.   THROMBOSIS AND HAEMOSTASIS

Improved Outcomes by Integrated Care of Anticoagulated Patients with Atrial Fibrillation Using the Simple ABC (Atrial Fibrillation Better Care) Pathway

(2018) Marco Proietti et al.   AMERICAN JOURNAL OF MEDICINE

Antithrombotic Therapy for Atrial Fibrillation

(2018) Gregory Y.H. Lip et al.   CHEST

National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Diagnosis and Management of Atrial Fibrillation 2018

(2018) David Brieger et al.   Heart Lung and Circulation

Integrated Care Management of Patients With Atrial Fibrillation and Risk of Cardiovascular Events

(2018) Daniele Pastori et al.   MAYO CLINIC PROCEEDINGS

Predicting Thromboembolic and Bleeding Event Risk in Patients with Non-Valvular Atrial Fibrillation: A Systematic Review

(2018) Ethan Borre et al.   THROMBOSIS AND HAEMOSTASIS

Temporal pattern/episode duration-based classification of atrial fibrillation as paroxysmal vs. persistent: is it time to develop a more integrated prognostic score to optimize management?

(2017) Matthew Hammond-Haley et al.   EUROPACE

European Society of Cardiology smartphone and tablet applications for patients with atrial fibrillation and their health care providers

(2017) Dipak Kotecha et al.   EUROPACE

The ABC pathway: an integrated approach to improve AF management

(2017) Gregory Y. H. Lip   Nature Reviews Cardiology

Assessing Bleeding Risk in Atrial Fibrillation Patients: Comparing a Bleeding Risk Score Based Only on Modifiable Bleeding Risk Factors against the HAS-BLED Score. The AMADEUS Trial

(2017) María Esteve-Pastor et al.   THROMBOSIS AND HAEMOSTASIS

Stroke prevention in atrial fibrillation: Past, present and future

(2017) Ben Freedman et al.   THROMBOSIS AND HAEMOSTASIS

Comparing the ORBIT and HAS-BLED bleeding risk scores in anticoagulated atrial fibrillation patients: a systematic review and meta-analysis

(2017) Cen Wang et al.   Oncotarget

Sex Differences in the Use of Oral Anticoagulants for Atrial Fibrillation: A Report From the National Cardiovascular Data Registry (NCDR ® ) PINNACLE Registry

(2017) Lauren E. Thompson et al.   Journal of the American Heart Association

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

(2016) Paulus Kirchhof et al.   EUROPEAN HEART JOURNAL

Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System

(2016) Jonathan L. Halperin et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The Future of Cardiovascular Medicine From the Regulatory Perspective

(2016) Robert M. Califf   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study

(2016) Ziad Hijazi et al.   LANCET

The HAS-BLED Score for Predicting Major Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: A Systematic Review and Meta-analysis

(2015) Wengen Zhu et al.   CLINICAL CARDIOLOGY

Evolution of the American College of Cardiology/American Heart Association Clinical Guidelines

(2015) Henry Han et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Performance of the HAS-BLED high bleeding-risk category, compared to ATRIA and HEMORR2HAGES in patients with atrial fibrillation: a systematic review and meta-analysis

(2014) Daniel Caldeira et al.   JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY

Health technology assessment in interventional electrophysiology and device therapy: a position paper of the European Heart Rhythm Association

(2013) G. Boriani et al.   EUROPEAN HEART JOURNAL

Lone atrial fibrillation - an overview

(2013) T. S. Potpara et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

(2013) Christian T Ruff et al.   LANCET

Use of the CHA 2 DS 2 -VASc and HAS-BLED Scores to Aid Decision Making for Thromboprophylaxis in Nonvalvular Atrial Fibrillation

(2012) Deirdre A. Lane et al.   CIRCULATION

A 12-Year Follow-up Study of Patients With Newly Diagnosed Lone Atrial Fibrillation

(2011) Tatjana S. Potpara et al.   CHEST

Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis

(2011) G. Y. H. Lip et al.   EUROPACE

A New Risk Scheme to Predict Warfarin-Associated Hemorrhage

(2011) Margaret C. Fang et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

(2010) Ron Pisters et al.   CHEST

Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

(2010) et al.   EUROPEAN HEART JOURNAL

Challenges in the classification of atrial fibrillation

(2010) Steven A. Lubitz et al.   Nature Reviews Cardiology

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

(2009) Gregory Y.H. Lip et al.   CHEST

Scientific Evidence Underlying the ACC/AHA Clinical Practice Guidelines

(2009) Pierluigi Tricoci   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

(2008) Gordon H Guyatt et al.   BMJ-British Medical Journal